Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells

• Published in: Journal of neuroscience methods 2016-06, Vol.266, p.42-49
• Main Authors: Hu, Yao, Qu, Zhuang-yin, Cao, Shi-ying, Li, Qi, Ma, Lixiang, Krencik, Robert, Xu, Min, Liu, Yan
• Format: Article
• Language: English
• Subjects: Adaptor Proteins, Signal Transducing - metabolism; Astrocytes - cytology; Astrocytes - physiology; Basal Forebrain - cytology; Basal Forebrain - physiology; Basal forebrain cholinergic neurons; Cell Culture Techniques - instrumentation; Cell Culture Techniques - methods; Cell Line; Choline O-Acetyltransferase - metabolism; Coculture Techniques - instrumentation; Coculture Techniques - methods; Embryonic Stem Cells - cytology; Embryonic Stem Cells - physiology; Forkhead Transcription Factors - metabolism; Human embryonic stem cells; Human induced pluripotent stem cells; Humans; Induced Pluripotent Stem Cells - cytology; Induced Pluripotent Stem Cells - physiology; Medial ganglionic eminence; Nerve Tissue Proteins - metabolism; Nestin - metabolism; Neural differentiation; Neurogenesis - physiology; Neurons - cytology; Neurons - physiology; PAX6 Transcription Factor - metabolism; SOXB1 Transcription Factors - metabolism; Thyroid Nuclear Factor 1 - metabolism
• ISSN: 0165-0270; 1872-678X
• DOI: 10.1016/j.jneumeth.2016.03.017

•Robust generation of basal forebrain cholinergic neurons (BFCNs) from human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs).•Co-culture with human astrocytes enhances differentiation efficiency of BFCNs.•Purmorphamine replaces SHH to produce BFCNs.•Generation of human BFCNs under xeno-free condition. Basal forebrain cholinergic neurons (BFCNs) play critical roles in learning, memory and cognition. Dysfunction or degeneration of BFCNs may connect to neuropathology, such as Alzheimer’s disease, Down’s syndrome and dementia. Generation of functional BFCNs may contribute to the studies of cell-based therapy and pathogenesis that is related to learning and memory deficits. Here we describe a detail method for robust generation of BFCNs from human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). In this method, BFCN progenitors are patterned from hESC or hiPSC-derived primitive neuroepithelial cells, with the treatment of sonic hedgehog (SHH) or combination with its agonist Purmorphamine, and by co-culturing with human astrocytes. At day 20, ∼90% hPSC-derived progenitors expressed NKX2.1, which is a transcriptional marker for MGE. Moreover, around 40% of NKX2.1+ cells co-expressed OLIG2 and ∼15% of NKX2.1+ cells co-expressed ISLET1, which are ventral markers. At day 35, ∼40% neurons robustly express ChAT, most of which are co-labeled with NKX2.1, ISLET1 and FOXG1, indicating the basal forebrain-like identity. At day 45, these neurons express mature neuronal markers MAP2, Synapsin, and VAChT. In this method, undefined conditions including genetic modification or cell-sorting are avoided. As a choice, feeder free conditions are used to avoid ingredients of animal origin. Moreover, Purmorphamine can be substituted for SHH to induce ventral progenitors effectively and economically. We provide an efficient method to generate BFCNs from multiple hPSC lines, which offers the potential application for disease modeling and pharmacological studies.